188 related articles for article (PubMed ID: 38384150)
1. Advancement in chiral heterocycles for the antidiabetic activity.
Gupta T; Rani D; Nainwal LM; Badhwar R
Chirality; 2024 Feb; 36(2):e23637. PubMed ID: 38384150
[TBL] [Abstract][Full Text] [Related]
2. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications.
Kerru N; Gummidi L; Maddila S; Gangu KK; Jonnalagadda SB
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326131
[TBL] [Abstract][Full Text] [Related]
3. Efficient methods for the synthesis of chiral 2-oxazolidinones as pharmaceutical building blocks.
Okuno K; Nishiyori R; Abe K; Mori T; Shirakawa S
Chirality; 2022 Jul; 34(7):915-924. PubMed ID: 35488466
[TBL] [Abstract][Full Text] [Related]
4. Role of sulphur-heterocycles in medicinal chemistry: An update.
Pathania S; Narang RK; Rawal RK
Eur J Med Chem; 2019 Oct; 180():486-508. PubMed ID: 31330449
[TBL] [Abstract][Full Text] [Related]
5. Organocatalytic Atroposelective Synthesis of Indole Derivatives Bearing Axial Chirality: Strategies and Applications.
Zhang HH; Shi F
Acc Chem Res; 2022 Sep; 55(18):2562-2580. PubMed ID: 36053083
[TBL] [Abstract][Full Text] [Related]
6. Modern advances in heterocyclic chemistry in drug discovery.
Taylor AP; Robinson RP; Fobian YM; Blakemore DC; Jones LH; Fadeyi O
Org Biomol Chem; 2016 Jul; 14(28):6611-37. PubMed ID: 27282396
[TBL] [Abstract][Full Text] [Related]
7. Pyrimidine: An elite heterocyclic leitmotif in drug discovery-synthesis and biological activity.
Nadar S; Khan T
Chem Biol Drug Des; 2022 Dec; 100(6):818-842. PubMed ID: 34914188
[TBL] [Abstract][Full Text] [Related]
8. The chemistry and biological activity of heterocycle-fused quinolinone derivatives: A review.
Shiro T; Fukaya T; Tobe M
Eur J Med Chem; 2015 Jun; 97():397-408. PubMed ID: 25532473
[TBL] [Abstract][Full Text] [Related]
9. Brønsted-acid-catalyzed asymmetric multicomponent reactions for the facile synthesis of highly enantioenriched structurally diverse nitrogenous heterocycles.
Yu J; Shi F; Gong LZ
Acc Chem Res; 2011 Nov; 44(11):1156-71. PubMed ID: 21800828
[TBL] [Abstract][Full Text] [Related]
10. [Efficient chiral control based on five-membered heterocyclic and related systems].
Kunieda T
Yakugaku Zasshi; 2000 Dec; 120(12):1323-35. PubMed ID: 11193382
[TBL] [Abstract][Full Text] [Related]
11. Potential-driven chirality manifestations and impressive enantioselectivity by inherently chiral electroactive organic films.
Sannicolò F; Arnaboldi S; Benincori T; Bonometti V; Cirilli R; Dunsch L; Kutner W; Longhi G; Mussini PR; Panigati M; Pierini M; Rizzo S
Angew Chem Int Ed Engl; 2014 Mar; 53(10):2623-7. PubMed ID: 24500795
[TBL] [Abstract][Full Text] [Related]
12. Organocatalytic Asymmetric Synthesis of Indole-Based Chiral Heterocycles: Strategies, Reactions, and Outreach.
Zhang YC; Jiang F; Shi F
Acc Chem Res; 2020 Feb; 53(2):425-446. PubMed ID: 31820922
[TBL] [Abstract][Full Text] [Related]
13. A review on antioxidant potential of bioactive heterocycle benzofuran: Natural and synthetic derivatives.
Chand K; Rajeshwari ; Hiremathad A; Singh M; Santos MA; Keri RS
Pharmacol Rep; 2017 Apr; 69(2):281-295. PubMed ID: 28171830
[TBL] [Abstract][Full Text] [Related]
14. Tandem construction of biological relevant aliphatic 5-membered N-heterocycles.
Łowicki D; Przybylski P
Eur J Med Chem; 2022 May; 235():114303. PubMed ID: 35344904
[TBL] [Abstract][Full Text] [Related]
15. Molecular Modeling Studies on Some Important Anticancer Heterocycles: An Overview.
Kale M; Sonwane G; Nawale R; Mourya V
Curr Comput Aided Drug Des; 2018; 14(3):178-190. PubMed ID: 29564984
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Medicinally Privileged Heterocycles through Dielectric Heating.
Bandyopadhyay D; Banik BK
Curr Med Chem; 2017; 24(41):4596-4626. PubMed ID: 28240166
[TBL] [Abstract][Full Text] [Related]
17. Trends in research of antitrypanosomal agents among synthetic heterocycles.
Kryshchyshyn A; Kaminskyy D; Grellier P; Lesyk R
Eur J Med Chem; 2014 Oct; 85():51-64. PubMed ID: 25072876
[TBL] [Abstract][Full Text] [Related]
18. Phthalazin-1(2H)-one as a remarkable scaffold in drug discovery.
Vila N; Besada P; Costas T; Costas-Lago MC; Terán C
Eur J Med Chem; 2015 Jun; 97():462-82. PubMed ID: 25482553
[TBL] [Abstract][Full Text] [Related]
19. Bioactive heterocycles containing endocyclic N-hydroxy groups.
Rani R; Granchi C
Eur J Med Chem; 2015 Jun; 97():505-24. PubMed ID: 25466924
[TBL] [Abstract][Full Text] [Related]
20. Chirality in metal-based anticancer agents.
Wang Y; Huang H; Zhang Q; Zhang P
Dalton Trans; 2018 Mar; 47(12):4017-4026. PubMed ID: 29479608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
